Silverberry Genomix Releases Corona Expert App

The new educational app provides a trusted source of information about the COVID-19 pandemic. 

San Francisco - November 13, 2020.  Silverberry Genomix, a leading company in digital health based in San Francisco, announced the release of the Corona Expert app, in partnership with Dana-Farber Research Insititute, an affiliated hospital of Harvard Medical School.

"We have been living in the pandemic for close to 10 months now. Nothing is more critical than having access to the correct medical information to keep the public informed with a trusted source of information", said Navid Madani, A Sr. Scientist at Dana Farber Institute and Director of SHE Center.

The first version of the app includes three components: FAQ, Articles, and Fact Check. By answering the most frequent questions about the disease, users can easily find short answers to the questions they might have. The Fact Check component, enables users to test their knowledge about the virus and the disease through gamification and a Trivia-Style experience. In addition to educational components, users may participate in a genomic study to better understand and respond to the current pandemic and future similar events.

 

"Since the start of the pandemic, Silverberry has been very active in providing services to its users and public to better manage their health and wellness" said Shayan Mashatian, Founder of Silverberry Genomix. After releasing of COVID-19 Impact Risk Report based on genetic variations found in a person, Corona Expert app is an important step in engaging with the public and provide a source of information for everyone that can be trusted and used. We invite researchers and health institutes globally to collaborate and make the app available to everyone around the world. ", he continued.

Corona Expert app is free and currently available on Apple Store in the English language. The Android version is pending approval to be released. The app will be available in 6 languages globally.

For more details and learn more about Silverberry response to the pandemic visit https://silverberrygenomix.com/coronavirus/

Silverberry response to the pandemic includes:

  • Corona Expert app
  • COVID-19 Genomic Study 
  • COVID-19 Impact Risk Report
  • COVID-19 Diagnostic Test for Businesses

About Silverberry Genomix

Silverberry Genomix is a leading digital health platform that utilizes AI and machine learning to provide personalized assessments and recommendations to optimize health and wellness plans. By offering a DNA Testing Kit, anyone can take the test and receive a personalized assessment as well as a wide range of recommendations. Those with an existing DNA file may upload their file and get access to Comprehensive DNA Health Reports. For more information visit https://silverberrygenomix.com/

 

Silverberry Genomix Releases DNA-Based COVID-19 Impact Risk Report

The new report analyzes the genetic makeup to identify individuals at greater risk who may experience severe illness if infected by the Coronavirus 2.

San Francisco - June 22, 2020.  Silverberry Genomix, a leading company in digital health based in San Francisco, announced the release of a new DNA-Based report to assess the impact risk of COVID-19.

Geneticists have turned up intriguing links between DNA and the COVID-19 disease. Some studies suggest that patients with certain types of genetic variation that is also known for predisposition to cognitive decline, seem to be at greater risk and may experience severe illness if infected by the Coronavirus 2 (SARS-CoV-2).

The new package, called “COVID-19 Impact Risk Report”, analyzes the genetic makeup to identify individuals at greater risk who may experience severe illness if infected by the virus.

To analyze the risk, Silverberry is using the regular DNA files produced by microarray and analyzes the SNPs reported in the files.

The new report is part of Silverberry Genomix’s response to the pandemic caused by the Coronavirus. The other activities include:

  • Corona Expert: FAQ and most recent updates about the virus.
  • COVID-19 Genomic Study.
  • Safe Office: Services to safely reopen dental offices.

For more information about the new report and order, visit https://silverberrygenomix.com/covid-19-impact-risk-assessment/

About Silverberry Genomix

Silverberry Genomix is a leading digital health platform that utilizes AI and machine learning to provide personalized assessments and recommendations to optimize health and wellness plans. By offering a DNA Testing Kit, anyone can take the test and receive a personalized assessment as well as a wide range of recommendations. Those with an existing DNA file may upload their file and get access to Comprehensive DNA Health Reports. For more information visit https://silverberrygenomix.com/

 

SHE Center at Dana-Farber and Silverberry Genomix form SHE Biobank, a Population Health Initiative for Research and Education

With a focus on ethnic minorities, the SHE Biobank provides an infrastructure for boosting research and education and improves response to pandemics.

April 23, 2020, Massachusetts and San Francisco - Science Health Education (SHE) Center at Dana-Farber Cancer Institute, and Silverberry Genomix, a leading company in digital health based in San Francisco, announced the launch of the SHE Biobank initiative. The SHE Center’s goal is to bring best practices, better health outcomes, and increased stability to developing countries including the Middle East and North America (MENA), a region urgently in need of all three. Navid Madani, Ph.D., the director of the SHE Center and a senior scientist at Dana-Farber Cancer Institute has led educational workshops and training programs in the region which reinforced the understanding of the current lack of health data infrastructure and solidified the need for such platforms in the region.

“The SHE Biobank is a large, long-term study that will investigate the impact of genetic predisposition and environmental exposure to the development of the disease,” said Madani. “Biobanking is crucial to this research and helps researchers, healthcare providers and governments to health policies and assign resources properly. “In recent years, due to advancements in healthcare technologies, data availability, and decreasing DNA sequencing costs, various biobanks have been created around the world.  However, the majority of such projects have been launched in developed countries, contributing to an increasing gap between developed and developing countries. This initiative aims to decrease that gap,” she said.

The SHE Biobank is unique in the educational support it offers researchers to conduct studies and the infrastructure it provides so the data can be put into action for the public good.  It also helps increase the readiness of the healthcare community to prevent or combat future disease outbreaks.

“The recent COVID-19 pandemic has shown the importance of the availability of digital health platforms to provide access to data and enable research and collaboration at scale for large size of population,” said Shayan Mashatian, Founder of Silverberry Genomix. “By making the Silverberry platform available to this critical endeavor, we are facilitating a rapid launch of the project, connecting the researchers, healthcare institutions, and other interested parties so more people can take advantage of scientific advancement, preventing disease or empower emerging field of precision medicine.”

Researchers, universities, government agencies, companies, and foundations as well as individual participants, are invited to participate in the initiative.

For more information about the initiative visit https://shebiobank.org or contact [email protected]

About SHE Center at Dana-Farber Institute, Harvard Medical School

Science Health Education Center (SHE) is a collaborative hub that promotes the Middle East and North Africa (MENA) region relevant research and capacity building through international training and scientific investigation, creating synergies between the MENA healthcare professionals and the Dana-Farber and Harvard communities. For more information visit https://www.dana-farber.org/science-health-education-center/research/

About Silverberry Genomix

Silverberry Genomix is a leading digital health platform that utilizes AI and machine learning to provide personalized assessments and recommendations to optimize health and wellness plans. By offering a DNA Testing Kit, anyone can take the test and receive a personalized assessment as well as a wide range of recommendations. Those with an existing DNA file may upload their file and get access to Comprehensive DNA Health Reports. For more information visit https://silverberrygenomix.com/

Media Contacts

For all inquiries, call 617-632-4090 and ask to speak to a member of the media team. Please direct emails to [email protected]

Silverberry Genomix announces a new genomic study for Coronavirus susceptibility in response to current COVID-19 pandemic

The new study intends to identify genomic susceptibility that alters either the rate of infection or the severity of the disease in response to the Coronavirus exposure.

April 13, 2020, San Francisco - Silverberry Genomix, a leader in the use of DNA testing for health and wellness announced a large scale genomic study in response to the current Coronavirus disease (COVID)-19 outbreak. 

The new study intends to identify genomic susceptibility that alters either the rate of infection or the severity of the disease in response to the coronavirus exposure. 

The study involves healthy participants that may or may not be exposed to COVID-19 and it will look into the effects of various factors including known risk factors such as age, comorbidities, and lifestyle choices such as smoking in the occurrence of COVID-19 symptomes. 

Collection of pre and post universal exposure data from a large number of people in different communities would enable Silverberry Genomix to effectively learn and come up with recommendations to counter future pandemics. 

Silverberry Genomix is a market leader by launching its digital health platform to create personalized assessment and recommendations for its users to better manage their health and wellness goals. The platform can be used as a biobank for population health studies to better understand diseases, run clinical trials for disease prevention or drug discovery. 

Study participants will have their genome analyzed for the presence of protective or susceptibility factors. Users with an existing DNA file can also upload their corresponding files. New users can use Silverberry DNA Test Kit at-home using a saliva swab. The study volunteers will participate in an ongoing survey and undergo analysis of their genetic markers. The goal of the study is to identify genomic variants that affect diseases in the healthier participants that can protect them against more severe diseases, and to use this knowledge for the development of novel therapies.

“We believe to address the current pandemic challenge, a data-driven approach is crucial, so researchers can have access to reliable data at large scale. By leveraging existing Silverberry Digital Health Platform, we are taking an important step toward that goal.” said Shayan Mashatian, Founder of Silverberry Genomix. "The comprehensive Silverberry platform already available plus a community of users who are well versed and keen about their health and wellness, provides a solid base for this study. It is a natural next step in expanding our service to address the most urgent issues endangering the society." he continued.

Silverberry Genomix has formed a Pandemic Scientific Task Force to oversee the study, including scientists with virology background, computential genomics, and data scientists. 

A Coronavirus Response Initiative has also been stated which includes comprehensive Frequently Asked Questions. Participants can register online to participate in the study.

For more information visit https://silverberrygenomix.com/covid-19-genomic-study/ 

Silverberry launches genei.us: The Personal Health Marketplace

Silverberry Genomix, a precision health company that uses DNA assessment for health and fitness, announced the launch of a new product, genei.us.

In order to help users draw greater benefits from their DNA reports as well as attract new health-conscious consumers, the minds behind Silverberry have created genei.us.

Genei.us is a membership based marketplace that allows users to browse content such as recipes, exercises, fitness gear, beauty products, and more based on their personal profile. When a user uploads their DNA test results, genei.us shows additional information on how each item is connected to the user’s genetic traits.

Consumers don’t have to have taken a DNA test to become a genei.us member. With a Silverberry Account, they can access the expertly selected list of items and start making use of the wealth of wellness information. In this sense, users can try before buying if they just want to see what genei.us is all about and what it has to offer. However, genei.us’ full potential becomes available once members have taken a DNA test and uploaded their results.

To encourage users to realize these full benefits and help them take advantage of everything genei.us has to offer, Silverberry is kicking off genei.us’ release with a set of special deals which include 3 month, one year, or lifetime membership, as well as steep discounts on their DNA kits. to learn more click  here.

For more info, visit genei.us.

IIlumina Accelerator is joining the Silverberry DNA Hackathon!

With great enthusiasm, Silverberry Genomix welcomes Illumina Accelerator to the Panel of Judges at the Silverberry DNA Data-Hackathon on July 20th 2018 at Galvanize in San Francisco!

The Illumina Clinical Services Laboratory is a proven and trusted partner in the new era of using genomic information to make critical health care decisions, and offers a comprehensive portfolio of clinical whole-genome sequencing tests intended to help both diagnose and assess risk for certain genetic diseases.

About the Event
The Data-Hackathon by Silverberry (#datathon) is bringing together data scientists, developers, designers, industry pros, and fitness enthusiasts over an intense 24-hour period of creative explosion to build and pitch solutions to build innovative DNA-powered consumer apps for fitness, nutrition, and everyday wellness decisions.
Event Page: https://silverberrygenomix.com/genomics-hackathon-for-data-science-and-health/

About Silverberry Genomix
We are a lifestyle company that uses the latest advancements in genomic sequencing to generate personalized DNA-driven wellness reports for fitness, nutrition, longevity, injury risk, skin care, allergy and personality development. We believe that the real value of DNA-driven assessments is the positive lifestyle changes they inspire, and we encourage many industries to unite in this valuable effort.

Free DNA-Based Wellness Reports for 23andMe, FamilyTreeDNA and Ancestry.com Users

September 19, 2017 – Silverberry, a DNA Lifestyle Company today announced availability of DNA-Based Wellness Reports to the users who have taken their DNA test with major ancestry service providers: 23andMe, FamilyTreeDNA and Ancestry.com

The above users can simply upload or sync their existing genotype file obtained from the above services and get access to Basic Wellness Reports instantly. Basic Wellness Package provides insight about genetic makeup in five different areas: Exercise Benefit, Nutrition, Skincare, Allergy and Personality Development. Report includes a combination of Nutrition and Exercise Reports, with Risk Assessments and Recommendations.

For more information visit Basic Wellness Package page on Silverberry website.

 

Silverberry Genomix Donates Proceeds to Harvey Recovery Efforts

San Francisco, September 5th, 2017 – In the aftermath of Hurricane Harvey, Silverberry Genomix, a DNA Lifestyle company which offers genomics wellness and health reports, announced it will donate a portion of its proceeds from the sales of its wellness reports during the month of September toward Hurricane Harvey recovery effotrs.

“We have been concerned about safety and health of the employees of FamilyTreeDNA and GenebyGene, our industry partners located in Houston”, said Shayan Mashatian, CEO of Silverberry Genomix. “We hope all those affected will go back to their normal life as soon as possible and our small contribution can help to make it happen sooner.”

In addition to this initiative, Silverberry also offers 50% discount on its service to the residents of Houston until end of September. Prospect users with the address in Houston, Texas should can [email protected] for details.

 

San Francisco Genomics Series: Happy Hour and Talk

San Francisco, August  30, 2017 – Silverberry Genomix, the DNA lifestyle Company, announced start of San Francisco Genomics Happy Hour and Talk series.

The monthly series is designed to bring genomics experts, data scientists, health and wellness experts as well as researchers and anyone interested in healthcare and new advancements together for knowledge sharing.

The format of events is an hour of networking, 30 to 45 minutes of talks followed with Q&A.

The first two events are scheduled as following:

September 7th: 
How Exercise Benefits the Brain
 
October 12th:
Nature and Nurture – How understanding our genes can help us achieve optimal wellness
You can also join the Meet Up group to receive notification and announcements for future events: https://www.meetup.com/San-Francisco-Genomics-Meetup/
For more information about the series contact [email protected]

 

About Silverberry

Silverberry Genomix is a DNA Lifestyle Company which utilizes the latest advances in genomics science and machine learning methods (AI) to generate personalized wellness reports based on your genes. Using the saliva sample, 150+ Reports are generated in the areas of Nutrition, Exercise, Skincare, Allergy and Personality Development.
For more information visit www.silerberrygenomix.com or email [email protected]

Silverberry Genomix to Exhibits at 9th Employer Healthcare and Benefits Congress in LA

San Francisco, August  11, 2017 – Silverberry Genomix, the DNA lifestyle Company, announced it will exhibit at 9th Employer Healthcare and Benefits Congress in Los Angeles, October 2-4, 2017.

The Employer Healthcare & Benefits Congress (EHBC) brings together attendees from across the world to discuss the latest developments in employee benefits industry, from corporate health & well-being programs and the latest in healthcare reform, to trends in voluntary benefits and self funded insurance, the EHBC has the information you need.

The EHBC Agenda is focused on the information corporate decision makers need to succeed. Whether  to know more about the latest information in healthcare reform, the latest developments in worksite wellness or the newest products.

Silverberry will offer its DNA wellness reports at a special rate to the congress attendees during the congress. Attendees can en EHBC as discount code to order their DNA kit or any of the Wellness report packages.

To meet with Silverberry team visit us at booth #739. Visit the Congress Website here.

About Silverberry

Silverberry Genomix is a DNA Lifestyle Company which utilizes the latest advances in genomics science and machine learning methods (AI) to generate personalized wellness reports based on your genes. Using the saliva sample, 150+ Reports are generated in the areas of Nutrition, Exercise, Skincare, Allergy and Personality Development.
For more information visit www.silerberrygenomix.com or email [email protected]

Silverberry Genomix Announces Formation of IRB (Internal Review Board)

San Francisco, July 28, 2017 –  Silverberry Genomix, the DNA lifestyle Company today announced formation of its internal IRB (Internal Review Board) for research and studies.

“Internal Review Boards are usually created by research organizations or government agencies to ensure ethical aspects of research and how users’ data is handled are supervised”, said Shayan Mashatian, CEO of Silverberry Genomix. “however, as many more companies at various sizes are joining the fast growing sector of interpreting health and genomics data, there is a need to self-regulate such activities beyond legal requirements” he continued.

In today’s  world of advanced science and technology, where new scientific findings can be converted to products and services through advanced technologies, it is important to think about long term effect of ethical and social implications of such studies as well as their legal aspects.

Therefore, at Silverberry Genomix, we have formed a committee of experts, inside and outside the company to discuss and supervise our studies’ methods and practices with user data, and publishing the results.

Silverberry’s IRB Committee is supervised by Susan Helm,  a healthcare industry veteran and Director of IRB at Pepperdine University.

About Silverberry Genomix

Silverberry Genomix is a DNA Lifestyle Company which utilizes the latest advances in genomics science and machine learning methods (AI) to generate personalized wellness reports based on your genes. Using the saliva sample, 150 Reports are generated in the areas of Nutrition, Exercise, Skincare, Allergy and Personality Development.
For more information contact [email protected]

Dr. Ahmad Salehi, Prominent Alzheimer Researcher Joins Silverberry as the Director of Cognitive Group

San Francisco, July 15, 2017 – We are pleased to announce  appointment of Dr. Ahmad Salehi, the prominent neuroscientist with many years of research focused on alzheimer’s and cognitive function, as the Director of Cognitive Group.

Dr. Salehi obtained his M.D. from the SBMU in Tehran and his Ph.D. in Neurobiology from the Netherlands Institute for Brain Research in Amsterdam. During this period, he was chosen as the best Junior Neuroscientist in the field of Alzheimer’s disease at the University of Leiden, the Netherlands. Following postdoctoral training(s) at the Netherlands Institute for Brain Research and the Department of Neurology and Neurological Sciences at Stanford Medical School in Palo Alto, California, he worked as a Senior Scientist at Stanford Medical School for more than 8 years.

In 2010, he received the World Technology Award in the field of biotechnology from the World Technology Network in Manhattan, New York for the use of multiple mouse models to identify genes involved in the pathogenesis of Down syndrome and Alzheimer’s disease. Salehi has numerous publications in peer-reviewed and high impact factor international journals of which, 7 have been featured on the cover.

Dr. Salehi will lead Silverberry research to study correlation among genetic predispositions and cognitive function for screening and potentially prevention or treatment of the disease.

About Silverberry Genomix

Silverberry Genomix is a DNA Lifestyle Company which utilizes the latest advances in genomics science and machine learning methods (AI) to generate personalized wellness reports based on your genes. Using the saliva sample, 150 Reports are generated in the areas of Nutrition, Exercise, Skincare, Allergy and Personality Development.
For more information contact [email protected]